Contact Us Today!

617-523-7900

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

Dean Eliott, M.D.

Associate Director, Retina Service
Specialties: Retina
Macular Degeneration Unit
Phone Number: 617-573-3736
Fax: 617-573-3698
Location: Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
Office Hours:
Location: Mass. Eye and Ear Retina Consultants
3 Woodland Road, Suite 210
Stoneham, MA 02180
Office Hours: 781-662-5520
Language:
Board Certification: Ophthalmology
MD Vanderbilt University School of Medicine
Residency Ophthalmology, Wilmer Eye Institute/Johns Hopkins Hospital
Fellowship Vitreoretinal Surgery, Duke University Medical Center
Teaching Affiliation Stelios Evangelos Gragoudas Associate Professor of Ophthalmology, Harvard Medical School
Biographical Profile:


Associate Director of the Mass. Eye and Ear Retina Service, Dr. Dean Eliott enjoys a national reputation as a gifted vitreoretinal surgeon and is sought by colleagues for difficult surgical cases. He is especially interested in treating retinal detachment, diabetic retinopathy, non-diabetic retinal vascular disease, trauma, and complex surgical problems.

After receiving his medical training from Vanderbilt University School of Medicine, Dr. Eliott completed his ophthalmology residency at Wilmer Eye Institute/Johns Hopkins Hospital. This was followed by a vitreoretinal fellowship at Duke University where he was also Chief Resident and a faculty member. Dr. Eliott then spent twelve years on the faculty at Kresge Eye Institute in Detroit where he was Director of the Retina Service and Retina Fellowship Director. Before coming to Mass. Eye and Ear, Dr. Eliott was Professor of Ophthalmology, Director of Clinical Affairs, and Director of Vitreoretinal Fellowship at the University of Southern California Keck School of Medicine’s Doheny Eye Institute in Los Angeles.

Dr. Eliott co-directs the Diabetic Eye Disease Center of Excellence at Harvard Medical School—a multidisciplinary collaboration among clinicians and scientists who are pooling their knowledge and resources with the goal of advancing breakthroughs in treatment for patients with diabetic eye disease. Additionally, he plays an important role training ophthalmology residents and fellows in the clinic and in the operating room as Director of the Retina Fellowship and Co-Director of Mass. Eye and Ear’s Vitrectomy Course. He also is a sought after regional, national, and international speaker.

In addition, Dr. Eliott has established a focused translational research program, where he is investigating ways to improve the diagnoses and outcomes for proliferative vitreoretinopathy; age-related macular degeneration; diabetic macular edema; and complex vitreoretinal surgical conditions, such as retinal detachment. As a clinical innovator and clinician scientist, Dr. Eliott is particularly interested in implantable and sustained-release steroid devices, vision-restoring electrical devices, and stem cell therapy. He continually receives research funding from the government and industry, and he has received several honors, including an American Academy of Ophthalmology Achievement Award, the Crystal Apple Teaching Award from the Young Physicians group of the American Society of Retina Specialists, and the Vitreous Society Honor Award. 

Research and Clinical Interests

Diabetic retinopathy, macular degeneration, retinal detachment, surgery for retina-vitreous disorders and ocular trauma

Publications

For a full publication list, please see his CV.

Retinal detachment after open globe injury. Stryjewski TP, Andreoli CM, Eliott D. Ophthalmology. 2014 Jan;121(1):327-333.

Fellow eye vitrectomy for proliferative diabetic retinopathy in an inner city population. Hwang JC, Sharma AG, Eliott D. Br J Ophthalmol. 2013 Mar;97(3):297-301.

Angiofibrotic response to VEGF inhibition in diabetic retinal detachment: report no. 1. Sohn EH, He S, Kim LA, Salehi-had H, Javaheri M, Spee C, Dustin L, Hinton DR, Eliott D. Arch Ophthalmol. 2012 Sep;130(9):1127-34.

Interim results from the international trial of Second Sight’s visual prosthesis. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ; Argus II Study Group. Ophthalmology. 2012 Apr;119(4):779-788.

Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Pearson PA, Comstock TL, Ip M, Callanan D, Morse LS, Ashton P, Levy B, Mann ES, Eliott D. Ophthalmology. 2011 Aug;118(8):1580-1587.  

View a list of publications on pubmed.gov »